Novo Nordisk buys manufacturing power as it seeks to ramp up Wegovy
Published
After struggling to keep up with patient demand for its weight-loss wonder drug Wegovy, Novo Nordisk said Monday that it is buying more manufacturing capacity. Novo Holdings, the Danish drugmaker’s controlling shareholder, said it acquired New Jersey-based Catalent Inc. in a deal that values the…
#wegovynovonordisk #novoholdings #danish #newjersey #catalentinc #novonordisk #novo #wegovy #glp1 #catalent